SALA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 6.297
AS - Asia 3.635
EU - Europa 2.776
SA - Sud America 499
Continente sconosciuto - Info sul continente non disponibili 384
AF - Africa 95
OC - Oceania 3
Totale 13.689
Nazione #
US - Stati Uniti d'America 5.978
SG - Singapore 1.221
IT - Italia 903
VN - Vietnam 740
CN - Cina 724
RU - Federazione Russa 417
BR - Brasile 373
DE - Germania 352
HK - Hong Kong 352
CA - Canada 210
IE - Irlanda 171
SE - Svezia 162
GB - Regno Unito 154
PL - Polonia 118
FR - Francia 117
IN - India 115
BD - Bangladesh 110
UA - Ucraina 82
KR - Corea 77
ID - Indonesia 68
FI - Finlandia 63
NL - Olanda 54
AR - Argentina 46
AT - Austria 44
DK - Danimarca 40
ZA - Sudafrica 37
TR - Turchia 33
JP - Giappone 32
IQ - Iraq 28
MX - Messico 28
EC - Ecuador 26
ES - Italia 26
PK - Pakistan 20
SA - Arabia Saudita 20
CO - Colombia 19
PH - Filippine 17
UZ - Uzbekistan 16
CH - Svizzera 14
VE - Venezuela 14
CR - Costa Rica 12
MY - Malesia 12
BE - Belgio 11
LT - Lituania 11
MA - Marocco 11
CL - Cile 8
GT - Guatemala 8
HN - Honduras 8
NI - Nicaragua 8
SV - El Salvador 8
PR - Porto Rico 7
TT - Trinidad e Tobago 7
DO - Repubblica Dominicana 6
EE - Estonia 6
JO - Giordania 6
SN - Senegal 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
EG - Egitto 5
KE - Kenya 5
PE - Perù 5
AZ - Azerbaigian 4
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
IR - Iran 4
JM - Giamaica 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
SC - Seychelles 4
TH - Thailandia 4
AL - Albania 3
AO - Angola 3
IL - Israele 3
NG - Nigeria 3
NO - Norvegia 3
PA - Panama 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
CZ - Repubblica Ceca 2
GD - Grenada 2
GY - Guiana 2
KW - Kuwait 2
LB - Libano 2
MN - Mongolia 2
MT - Malta 2
NA - Namibia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
AG - Antigua e Barbuda 1
AU - Australia 1
Totale 13.292
Città #
Ashburn 768
Singapore 747
San Jose 653
Ann Arbor 492
Hong Kong 342
Milan 263
Ho Chi Minh City 224
Council Bluffs 210
Woodbridge 203
Wilmington 192
Hanoi 177
Fairfield 176
Dublin 161
New York 155
Houston 150
Hefei 148
Frankfurt am Main 144
Santa Clara 140
Chandler 115
Dallas 107
Beijing 100
Los Angeles 95
Kraków 94
Chicago 91
Seattle 87
Dearborn 83
Seoul 73
Jacksonville 67
Cambridge 65
Rome 62
Boardman 60
Toronto 59
The Dalles 53
Jakarta 51
São Paulo 50
Moscow 47
Buffalo 42
Lauterbourg 38
Columbus 35
Da Nang 35
Vienna 35
Princeton 34
Shanghai 33
Phoenix 31
Helsinki 30
Nanjing 29
Chennai 27
Atlanta 26
Denver 26
Dong Ket 26
Montreal 26
Tokyo 26
Orem 25
Haiphong 24
Warsaw 24
Washington 21
Brooklyn 20
Johannesburg 19
Figino 18
Munich 18
Turin 18
Salt Lake City 17
Stockholm 17
Florence 16
Lissone 15
North Bergen 15
Ottawa 15
Padova 15
Altamura 14
Hyderabad 14
Lawrence 14
London 14
Tashkent 14
Amsterdam 13
Hải Dương 13
Manchester 13
Nanchang 13
Naples 13
Nuremberg 13
Tianjin 13
Vũng Tàu 13
Biloxi 12
Edmonton 12
Quận Bình Thạnh 12
Biên Hòa 11
Can Tho 11
Hebei 11
Lappeenranta 11
Philadelphia 11
Turku 11
Boston 10
Brussels 10
Guayaquil 10
Mumbai 10
Poplar 10
Rio de Janeiro 10
San Diego 10
Torino 10
Baghdad 9
Bắc Ninh 9
Totale 7.874
Nome #
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 534
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 517
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 500
Action potential contour contributes to species differences in repolarization response to b-adrenergic stimulation 495
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients 485
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension 447
Prevention of myocardial remodeling by chronic INaL blockade in pulmonary hypertension 433
Late sodium current (INaL) in pancreatic β-cells 419
Altered functional differentiation of mesoangioblasts in a genetic myopathy 412
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 410
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 385
IKr Impact on Repolarization and Its Variability Assessed by Dynamic Clamp 380
The Dynamic Clamp Technique: A Robust Toolkit for Investigating Potassium Channel Function 367
Aberrant Functional Differentiation of Cardiac Precursors from a Dystrophic Mouse 366
Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation 350
Membrane-targeted push-pull azobenzenes for the optical modulation of membrane potential 340
Long QT Syndrome modelled with human induced pluripotent stem cells (hiPSc) 339
Musclemotion: A versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo 321
Identification and functional characterisation of a new KCNJ2 mutation 303
A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes 288
Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry 262
Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation 260
Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification 240
Geneless optomodulation of cardiomyocytes membrane potential by sarcolemma-targeted azobenzene photoswitches 234
The impact of genetics on the long QT syndrome: myth or reality? 209
Rescue of loss-of-function long QT syndrome-associated mutations in KV7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S) 206
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19 202
Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants 199
Use of hiPSC-derived cardiomyocytes to study LQTS-variant specific proarrhythmic effects of drugs 198
Cardiac microtissues from human pluripotent stem cells recapitulate the phenotype of long-QT syndrome 197
Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling 197
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2 192
Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes Carrying CALM1-F142l Mutation Recapitulate LQTS Phenotype in Vitro 189
Continuous Bayesian Variant Interpretation Accounts for Incomplete Penetrance among Mendelian Cardiac Channelopathies 183
Geneless optomodulation of cardiomyocytes membrane potential by membrane-targeted azobenzene photoswitches 179
Precision Medicine and cardiac channelopathies: When dreams meet reality 159
Advances in pluripotent stem cell-based in vitro models of the human heart for cardiac physiology, disease modeling and clinical applications 157
Electrophysiological analysis of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) using multi-electrode arrays (MEAs) 153
Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease 152
Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells 145
Cardiac Repolarization and Stem Cells: An Emerging Path Toward Precision Medicine 141
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells 140
Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come? 140
A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells 137
Quantification of Muscle Contraction In Vitro and In Vivo Using MUSCLEMOTION Software: From Stem Cell-Derived Cardiomyocytes to Zebrafish and Human Hearts 135
Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced Arrhythmias 133
Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes 132
Precision versus traditional medicine - Clinical questions trigger progress in basic science: A favor not always returned 104
A platform for assessing pro- and anti-arrhythmic effects of drugs based on isogenic human iPSC-derived cardiomyocytes 88
A novel optoelectronic platform combining LED-driven pacing and laser optoporation for high-throughput cardiac electrophysiology 69
High-throughput contractility analysis platform for drug-response evaluation of hiPSC-derived cardiac models based on dynamic frequency conditioning 60
Non-invasive action potential recordings using printed electrolyte-gated polymer field-effect transistors 59
Cardiomyocyte-stromal cell interplay modulates the pathogenesis of arrhythmogenic cardiomyopathy 56
Beyond Transconductance: Cell-Polymer Coupling Determines Fidelity in Action Potential Recording via Electrolyte-Gated Polymer Transistors 53
SGK1-inhibition restores cardiac repolarization in LQT2 rabbits and LQT3 mice by reducing late sodium current 50
Machine learning-guided risk stratification for long QT syndrome genetic variants with hiPSC-derived cardiomyocytes 44
Cardiomyocyte - stromal cells interplay as a novel platform for mechanistic insights in arrhythmogenic cardiomyopathy 40
VAE-MOTION: A deep generative model for cardiomyocyte contractility analysis for improving drug efficacy evaluation 39
An organic artificial cardiomyocyte 36
null 29
Totale 13.689
Categoria #
all - tutte 42.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022207 0 0 0 0 10 32 15 17 19 36 28 50
2022/2023632 63 162 52 54 24 70 15 88 60 13 21 10
2023/2024694 13 18 34 41 80 167 127 45 70 22 13 64
2024/20252.213 74 215 218 71 139 85 124 89 167 351 174 506
2025/20265.308 673 434 341 596 576 239 894 213 380 413 250 299
2026/20272.054 127 374 550 875 128 0 0 0 0 0 0 0
Totale 13.689